孟德尔随机化
动脉粥样硬化性心血管疾病
内科学
胆固醇
全基因组关联研究
内分泌学
脂蛋白
高密度脂蛋白
心血管健康
医学
胆固醇逆向转运
疾病
心脏病学
生物
遗传学
遗传变异
单核苷酸多态性
基因型
基因
作者
Shiva Ganjali,Gerald F. Watts,Maciej Banach,Željko Reiner,Petr Nachtigal,Amirhossein Sahebkar
标识
DOI:10.2174/0929867328666210208182326
摘要
The inverse relationship between low plasma high-density lipoprotein cholesterol (HDL-C) concentrations and increased risk of Atherosclerotic Cardiovascular Disease (ASCVD) is well-known. However, plasma HDL-C concentrations are highly variable in subjects with ASCVD. In clinical outcome trials, pharmacotherapies that increase HDL-C concentrations are not associated with a reduction in ASCVD events. A causal relationship between HDL-C and ASCVD has also been questioned by Mendelian randomization studies and genome-wide association studies of genetic variants associated with plasma HDL-C concentrations. The U-shaped association between plasma HDL-C concentrations and mortality observed in several epidemiological studies implicates both low and very high plasma HDL-C concentrations in the etiology of ASCVD and non- ASCVD mortality. These data do not collectively support a causal association between HDL-C and ASCVD risk. Therefore, the hypothesis concerning the association between HDL and ASCVD has shifted from focus on plasma concentrations to the concept of functionality, in particular cellular cholesterol efflux and HDL holoparticle transport. In this review, we focus on these new concepts and provide a new framework for understanding and testing the role of HDL in ASCVD.
科研通智能强力驱动
Strongly Powered by AbleSci AI